Cargando…
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
AIM: Statin‐associated muscle symptoms (SAMS) are a major determinant of poor treatment adherence and/or discontinuation, but a definitive diagnosis of SAMS is challenging. The PROSISA study was an observational retrospective study aimed to assess the prevalence of reported SAMS in a cohort of dysli...
Autores principales: | Casula, M., Gazzotti, M., Bonaiti, F., OImastroni, E., Arca, M., Averna, M., Zambon, A., Catapano, A.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359216/ https://www.ncbi.nlm.nih.gov/pubmed/33259671 http://dx.doi.org/10.1111/joim.13219 |
Ejemplares similares
-
Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020) -
Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022) -
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023) -
Interaction Study on Garlic and Atorvastatin with Reference to Nephrotoxicity in Dyslipidaemic Rats
por: Reddy, G. Dilip, et al.
Publicado: (2010) -
Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia
por: Adegoke, Samuel Ademola, et al.
Publicado: (2016)